Assessment of pathogenic micro-organisms in commercially available smokeless tobacco products
Guardado en:
Autores principales: | Pooja J Shetty, Vijaya Hegde |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fc4ce93cbcad491b83753298d006fd30 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The health impact of smokeless tobacco products: a systematic review
por: C. Hajat, et al.
Publicado: (2021) -
Plasma Cotinine Is Positively Associated with Homocysteine in Smokers but Not in Users of Smokeless Tobacco
por: Elisabet Söderström, et al.
Publicado: (2021) -
Smokeless tobacco use: a risk factor for hyperhomocysteinemia in a Pakistani population.
por: Mohammad Perwaiz Iqbal, et al.
Publicado: (2013) -
A qualitative study to assess perceptions, barriers, and motivators supporting smokeless tobacco cessation in the US fire service.
por: Nattinee Jitnarin, et al.
Publicado: (2021) -
Smokeless Tobacco Use and Ischemic Stroke: A Cross-Sectional Study
por: Maimoona Siddiqui, et al.
Publicado: (2016)